322
Views
9
CrossRef citations to date
0
Altmetric
Articles

Prevalence and Correlates of Depressive Symptomology among Young Adults Who Use Prescription Opioids Non-medically

, ScB, , MSc, , MPA, , MD, PhD, , MS, , PhD, MSc, , MD, MPH & , PhDORCID Icon show all
Pages 441-452 | Received 12 Jul 2018, Accepted 29 May 2019, Published online: 14 Aug 2019

References

  • Ali, M. M., D. Dean Jr., R. Lipari, W. N. Dowd, A. P. Aldridge, and S. P. Novak. 2015. The mental health consequences of nonmedical prescription drug use among adolescents. The Journal of Mental Health Policy and Economics 18 (1):3–15.
  • Allgaier, A. K., K. Krick, A. Opitz, B. Saravo, M. Romanos, and G. Schulte-Korne. 2014. Improving early detection of childhood depression in mental health care: the Childrens Depression Screener (ChilD-S). Psychiatry Research 217 (3):248–52. doi:10.1016/j.psychres.2014.03.037.
  • Amari, E., J. Rehm, E. Goldner, and B. Fischer. 2011. Nonmedical prescription opioid use and mental health and pain comorbidities: A narrative review. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie 56 (8):495–502. doi:10.1177/070674371105600808.
  • Andresen, E. M., J. A. Malmgren, W. B. Carter, and D. L. Patrick. 1994. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). American Journal of Preventive Medicine 10 (2):77–84.
  • Becker, W. C., L. E. Sullivan, J. M. Tetrault, R. A. Desai, and D. A. Fiellin. 2008. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug and Alcohol Dependence 94 (1–3):38–47. doi:10.1016/j.drugalcdep.2007.09.018.
  • Bjorgvinsson, T., S. J. Kertz, J. S. Bigda-Peyton, K. L. McCoy, and I. M. Aderka. 2013. Psychometric properties of the CES-D-10 in a psychiatric sample. Assessment 20 (4):429–36. doi:10.1177/1073191113481998.
  • Boyd, C. J., S. E. McCabe, J. A. Cranford, and A. Young. 2006. Adolescents’ motivations to abuse prescription medications. Pediatrics 118 (6):2472–80. doi:10.1542/peds.2006-1644.
  • Branstrom, R., and J. E. Pachankis. 2018. Validating the syndemic threat surrounding sexual minority men’s health in a population-based study with national registry linkage and a heterosexual comparison. Journal of Acquired Immune Deficiency Syndromes 78 (4):376–82. doi:10.1097/QAI.0000000000001697.
  • Carpenter, J. S., M. A. Andrykowski, J. Wilson, L. A. Hall, M. K. Rayens, B. Sachs, and L. L. Cunningham. 1998. Psychometrics for two short forms of the Center for Epidemiologic Studies-Depression Scale. Issues in Mental Health Nursing 19 (5):481–94.
  • Center for Behavioral Health Statistics and Quality. 2016. 2015 National Survey on Drug Use and Health: Detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration.
  • Cerda, M., J. Santaella, B. D. Marshall, J. H. Kim, and S. S. Martins. 2015. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: A national study. The Journal of Pediatrics 167 (3):605-12 e1-2. doi:10.1016/j.jpeds.2015.04.071.
  • Chahua, M., L. Sordo, G. Barrio, A. Domingo-Salvany, M. T. Brugal, G. Molist, L. de la Fuente, M. J. Bravo, and Itinere Project Group. 2014. Non-fatal opioid overdose and major depression among street-recruited young heroin users. European Addiction Research. 20 (1):1–7. doi:10.1159/000346787.
  • Chen, L. H., H. Hedegaard, and M. Warner. 2014. Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS Data Brief (166):1–8. https://www.cdc.gov/nchs/data/databriefs/db166.pdf
  • Cornford, C. S., K. Umeh, and N. Manshani. 2012. Heroin users’ experiences of depression: a qualitative study. Family Practice 29 (5):586–92. doi:10.1093/fampra/cms014.
  • Dow, S. J., and J. F. Kelly. 2013. Listening to youth: Adolescents’ reasons for substance use as a unique predictor of treatment response and outcome. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors 27 (4):1122–31. doi:10.1037/a0031065.
  • Drazdowski, T. K. 2016. A systematic review of the motivations for the non-medical use of prescription drugs in young adults. Drug and Alcohol Dependence 162:3–25. doi:10.1016/j.drugalcdep.2016.01.011.
  • Edlund, M. J., V. L. Forman-Hoffman, C. R. Winder, D. C. Heller, L. A. Kroutil, R. N. Lipari, and L. J. Colpe. 2015. Opioid abuse and depression in adolescents: Results from the National Survey on Drug Use and Health. Drug and Alcohol Dependence 152:131–38. doi:10.1016/j.drugalcdep.2015.04.010.
  • Fink, D. S., R. Hu, M. Cerda, K. M. Keyes, B. D. Marshall, S. Galea, and S. S. Martins. 2015. Patterns of major depression and nonmedical use of prescription opioids in the United States. Drug and Alcohol Dependence 153:258–64. doi:10.1016/j.drugalcdep.2015.05.010.
  • Fischer, B., A. Lusted, M. Roerecke, B. Taylor, and J. Rehm. 2012. The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis. The Journal of Pain : Official Journal of the American Pain Society 13 (11):1029–44. doi:10.1016/j.jpain.2012.07.013.
  • Frank, D., P. Mateu-Gelabert, H. Guarino, A. Bennett, T. Wendel, L. Jessell, and A. Teper. 2015. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users. The International Journal on Drug Policy 26 (1):84–91. doi:10.1016/j.drugpo.2014.07.013.
  • Garland, E. L., C. Pettus-Davis, and M. O. Howard. 2013. Self-medication among traumatized youth: structural equation modeling of pathways between trauma history, substance misuse, and psychological distress. Journal of Behavioral Medicine 36 (2):175–85. doi:10.1007/s10865-012-9413-5.
  • Garnier-Dykstra, L. M., K. M. Caldeira, K. B. Vincent, K. E. O’Grady, and A. M. Arria. 2012. Nonmedical use of prescription stimulants during college: four-year trends in exposure opportunity, use, motives, and sources. Journal of American College Health : J of ACH 60 (3):226–34. doi:10.1080/07448481.2011.589876.
  • Goldner, E. M., A. Lusted, M. Roerecke, J. Rehm, and B. Fischer. 2014. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses. Addictive Behaviors 39 (3):520–31. doi:10.1016/j.addbeh.2013.11.022.
  • Goodman, I., M. Peterson-Badali, and J. Henderson. 2011. Understanding motivation for substance use treatment: the role of social pressure during the transition to adulthood. Addictive Behaviors 36 (6):660–68. doi:10.1016/j.addbeh.2011.01.011.
  • Green, T. C., J. M. Grimes Serrano, A. Licari, S. H. Budman, and S. F. Butler. 2009. Women who abuse prescription opioids: Findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug and Alcohol Dependence 103 (1–2):65–73. doi:10.1016/j.drugalcdep.2009.03.014.
  • Green, T. C., R. Black, J. M. Grimes Serrano, S. H. Budman, and S. F. Butler. 2011. Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. PloS One 6 (11):e27244. doi:10.1371/journal.pone.0027244.
  • Hadland, S. E., B. D. Marshall, T. Kerr, J. Qi, J. S. Montaner, and E. Wood. 2011. Depressive symptoms and patterns of drug use among street youth. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine 48 (6):585–90. doi:10.1016/j.jadohealth.2010.09.009.
  • Hadland, S. E., and E. Wood. 2012. Commentary on Bruneau et al. (2012): injection of prescription opioid pain relievers and infectious disease risk. Addiction 107 (7):1328–29. doi:10.1111/j.1360-0443.2012.03885.x.
  • Han, B., W. M. Compton, C. Blanco, E. Crane, J. Lee, and C. M. Jones. 2017. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Annals of Internal Medicine 167 (5):293. doi:10.7326/M17-0865.
  • Harrell, F. J. 2015. Regression modeling strategies. New York, NY: Springer International Publishing.
  • Hartung, C. M., W. H. Canu, C. S. Cleveland, E. K. Lefler, M. J. Mignogna, D. A. Fedele, C. J. Correia, T. R. Leffingwell, and J. D. Clapp. 2013. Stimulant medication use in college students: comparison of appropriate users, misusers, and nonusers. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors 27 (3):832–40. doi:10.1037/a0033822.
  • Jones, C. M., J. Logan, R. M. Gladden, and M. K. Bohm. 2015. Vital signs: Demographic and substance use trends among heroin users - United States, 2002-2013. MMWR. Morbidity and Mortality Weekly Report 64 (26):719–25.
  • Kessler, R. C. 2004. The epidemiology of dual diagnosis. Biological Psychiatry 56 (10):730–37. doi:10.1016/j.biopsych.2004.06.034.
  • Khantzian, E. J. 1997. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry 4 (5):231–44. doi:10.3109/10673229709030550.
  • Kilburn, K., L. Prencipe, L. Hjelm, A. Peterman, S. Handa, and T. Palermo. 2018. Examination of performance of the Center for Epidemiologic Studies Depression Scale Short Form 10 among African youth in poor, rural households. BMC Psychiatry 18 (1):201. doi:10.1186/s12888-018-1774-z.
  • Kohout, F. J., L. F. Berkman, D. A. Evans, and J. Cornoni-Huntley. 1993. Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. Journal of Aging and Health 5 (2):179–93. doi:10.1177/089826439300500202.
  • Kolodny, A., D. T. Courtwright, C. S. Hwang, P. Kreiner, J. L. Eadie, T. W. Clark, and G. C. Alexander. 2015. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annual Review of Public Health 36:559–74. doi:10.1146/annurev-publhealth-031914-122957.
  • Lankenau, S. E., M. Teti, K. Silva, J. Jackson Bloom, A. Harocopos, and M. Treese. 2012b. Initiation into prescription opioid misuse amongst young injection drug users. The International Journal on Drug Policy 23 (1):37–44. doi:10.1016/j.drugpo.2011.05.014.
  • Lankenau, S. E., M. Teti, K. Silva, J. J. Bloom, A. Harocopos, and M. Treese. 2012a. Patterns of prescription drug misuse among young injection drug users. Journal of Urban Health : Bulletin of the New York Academy of Medicine 89 (6):1004–16. doi:10.1007/s11524-012-9691-9.
  • Lima, V. D., R. Harrigan, M. Murray, D. M. Moore, E. Wood, R. S. Hogg, and J. S. Montaner. 2008. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS 22 (17):2371–80. [pii]: 00002030-200811120-00017. doi:10.1097/QAD.0b013e328315cdd3.
  • Mackesy-Amiti, M. E., G. R. Donenberg, and L. J. Ouellet. 2015. Prescription opioid misuse and mental health among young injection drug users. The American Journal of Drug and Alcohol Abuse 41 (1):100–06. doi:10.3109/00952990.2014.940424.
  • Marshall, B. D. L., T. C. Green, B. Elston, J. L. Yedinak, S. E. Hadland, and M. A. Clark. 2018. The effectiveness of internet- and field-based methods to recruit young adults who use prescription opioids nonmedically. Substance Use & Misuse 53 (10):1688–99. doi:10.1080/10826084.2018.1425725.
  • Marshall, B. D. L., T. C. Green, J. L. Yedinak, and S. E. Hadland. 2016. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. International Journal of Drug Policy 31:25–31. doi:10.1016/j.drugpo.2016.01.022.
  • Martins, S. S., L. E. Segura, J. Santaella-Tenorio, A. Perlmutter, M. C. Fenton, M. Cerdá, K. M. Keyes, L. A. Ghandour, C. L. Storr, and D. S. Hasin. 2017. Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014. Addictive Behaviors 65 (Supplement C):236–41. doi:10.1016/j.addbeh.2016.08.033.
  • Martins, S. S., M. C. Fenton, K. M. Keyes, C. Blanco, H. Zhu, and C. L. Storr. 2012. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychological Medicine 42 (6):1261–72. doi:10.1017/s0033291711002145.
  • McCabe, S. E., J. A. Cranford, C. J. Boyd, and C. J. Teter. 2007. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addictive Behaviors 32 (3):562–75. doi:10.1016/j.addbeh.2006.05.022.
  • National Institute on Drug Abuse. 2011. NIDA research report series: Prescription drug abuse. Bethesda, MD: National Institutes of Health.
  • Nyamathi, A., B. Leake, C. Albarran, S. Zhang, E. Hall, D. Farabee, E. Marlow, M. Marfisee, F. Khalilifard, and M. Faucette. 2011. Correlates of depressive symptoms among homeless men on parole. Issues in Mental Health Nursing 32 (8):501–11. doi:10.3109/01612840.2011.569111.
  • Pachankis, J. E., M. L. Hatzenbuehler, K. Wang, C. L. Burton, F. W. Crawford, J. C. Phelan, and B. G. Link. 2018. The burden of stigma on health and well-being: A taxonomy of concealment, course, disruptiveness, aesthetics, origin, and peril across 93 stigmas. Personality & Social Psychology Bulletin 44 (4):451–74. doi:10.1177/0146167217741313.
  • Risser, J., A. Cates, H. Rehman, and W. Risser. 2010. Gender differences in social support and depression among injection drug users in Houston, Texas. The American Journal of Drug and Alcohol Abuse 36 (1):18–24. doi:10.3109/00952990903544802.
  • Rowe, C. L., H. A. Liddle, P. E. Greenbaum, and C. E. Henderson. 2004. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. Journal of Substance Abuse Treatment 26 (2):129–40. doi:10.1016/S0740-5472(03)00166-1.
  • Salas, J., J. F. Scherrer, P. J. Lustman, and F. D. Schneider. 2016. Racial differences in the association between nonmedical prescription opioid use, abuse/ dependence,and major depression. Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse 37 (1):25–30. doi:10.1080/08897077.2015.1129523.
  • Simoni-Wastila, L., and C. Tompkins. 2001. Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Substance Use & Misuse 36 (9–10):1275–96.
  • Sordo, L., M. Chahua, M. J. Bravo, G. Barrio, M. T. Brugal, A. Domingo-Salvany, G. Molist, L. De la Fuente, and Itinere Project Group. 2012. Depression among regular heroin users: the influence of gender. Addictive Behaviors. 37 (1):148–52. doi:10.1016/j.addbeh.2011.09.009.
  • Surratt, H., S. P. Kurtz, and T. J. Cicero. 2011. Alternate routes of administration and risk for HIV among prescription opioid abusers. Journal of Addictive Diseases 30 (4):334–41. doi:10.1080/10550887.2011.609805.
  • Tobin, K. E., and C. A. Latkin. 2003. The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland. Journal of Urban Health : Bulletin of the New York Academy of Medicine 80 (2):220–29. doi:10.1093/jurban/jtg025.
  • Twombly, E. C., and K. D. Holtz. 2008. Teens and the misuse of prescription drugs: evidence-based recommendations to curb a growing societal problem. The Journal of Primary Prevention 29 (6):503–16. doi:10.1007/s10935-008-0157-5.
  • Wang, K., C. L. Burton, and J. E. Pachankis. 2018. Depression and substance use: Towards the development of an emotion regulation model of stigma coping. Substance Use & Misuse 53 (5):859–66. doi:10.1080/10826084.2017.1391011.
  • Wang, P., H. C. Wu, C. N. Yen, Y. C. Yeh, K. S. Chung, H. C. Chang, and C. F. Yen. 2012. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors 26 (1):145–50. doi:10.1037/a0025175.
  • White Hughto, J. M., J. E. Pachankis, T. C. Willie, and S. L. Reisner. 2017. Victimization and depressive symptomology in transgender adults: The mediating role of avoidant coping. Journal of Counseling Psychology 64 (1):41–51. doi:10.1037/cou0000184.
  • World Health Organization. 2009. Clinical guidelines for withdrawal management and treatment of drug dependence in closed settings. Geneva.
  • Wu, Y., S. Yan, Y. Bao, Z. Lian, Z. Qu, and Z. Liu. 2016. Cross-sectional study of the severity of self-reported depressive symptoms in heroin users who participate in a methadone maintenance treatment program. Shanghai Archives of Psychiatry 28 (1):35–41. doi:10.11919/j.issn.1002-0829.215127.
  • Young, A. M., N. Glover, and J. R. Havens. 2012a. Nonmedical use of prescription medications among adolescents in the United States: a systematic review. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine 51 (1):6–17. doi:10.1016/j.jadohealth.2012.01.011.
  • Young, A. M., S. E. McCabe, J. A. Cranford, P. Ross-Durow, and C. J. Boyd. 2012b. Nonmedical use of prescription opioids among adolescents: subtypes based on motivation for use. Journal of Addictive Diseases 31 (4):332–41. doi:10.1080/10550887.2012.735564.
  • Zhang, W., N. O’Brien, J. I. Forrest, K. A. Salters, T. L. Patterson, J. S. Montaner, R. S. Hogg, and V. D. Lima. 2012. Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PloS One 7 (7):e40793. doi:10.1371/journal.pone.0040793.
  • Zou, G. 2004. A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology 159 (7):702–06. doi:10.1093/aje/kwh090.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.